Skip to main content
Clinical Trials/JPRN-UMIN000008371
JPRN-UMIN000008371Completed未知

Clinical observation study of 5-year survivals in patients with newly diagnosed acute myelogenous leukemia (AML), myelodysplastic syndromes (MDS), and chronic myelomonocytic leukemia (CMML) in Japan Adult Leukemia Study Group - JALSG AML/MDS/CMML Clinical Observational Study (JALSG-CS)-11

Japan Adult Leukemia Study Group0 sites6,100 target enrollmentStarted: July 20, 2012Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
6,100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
16years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •Past history of chemotherapy or stem cell transplantation in the treatment of AML, MDS, or CMM

Investigators

Similar Trials